Search Follow us
Refine By

Stock Exchange

Market Cap (m)

Type of Publication

biopharma credit

1 - 1 of 1
Sort by: popularity | newest
Page  of 1
BioPharma Credit

Leading lender in life sciences

Initiation | Investment Companies | 17 May 2018

BioPharma Credit (BPCR) offers investors access to a diverse portfolio of secured debt instruments for life science companies based on BPCR's pool of investment opportunities. The ongoing specialisation and fragmentation of the drug discovery process is translating into an increased number of market players seeking additional funding backed by sales from approved products and/or royalty streams from out-licensed products. During its IPO in March 2017 and follow-on placings, the trust has so far raised gross proceeds of US$1,080m (of which US$339m is in seed assets) and already deployed US$690m in four large deals. It also has outstanding potential commitments of up to US$350m.